Suchergebnisse - "Mortezaee, Keywan"

PubPharm (12)

1

WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses

enthalten in: Clinical and experimental medicine | 2024

von Mortezaee, K.

2

Modifying CAR-T cells with anti-checkpoints in cancer immunotherapy : A focus on anti PD-1/PD-L1 antibodies

enthalten in: Life sciences | 2024

von Najafi, S. | Mortezaee, K.

3

Dual anti-PD-(L)1/TGF-β inhibitors in cancer immunotherapy - Updated

enthalten in: International immunopharmacology | 2023

von Karami, Z. | Mortezaee, K. | Majidpoor, J.

4

The impact of PD-L1 as a biomarker of cancer responses to combo anti-PD-1/CTLA-4

enthalten in: Pathology, research and practice | 2023

von Parvini, S. | Majidpoor, J. | Mortezaee, K.

5

HHLA2 immune-regulatory roles in cancer

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Mortezaee, K.

6

The impact of oncolytic adenoviral therapy on the therapeutic efficacy of PD-1/PD-L1 blockade

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Najafi, S. | Majidpoor, J. | Mortezaee, K.

7

B7x in cancer immunity and immunotherapy

enthalten in: International immunopharmacology | 2023

von Mortezaee, K.

8

Transforming growth factor-β signalling in tumour resistance to the anti-PD-(L)1 therapy : Updated

enthalten in: Journal of cellular and molecular medicine | 2023

von Mortezaee, K. | Majidpoor, J.

9

The impact of microbiota on PD-1/PD-L1 inhibitor therapy outcomes : A focus on solid tumors

enthalten in: Life sciences | 2022

von Najafi, S. | Majidpoor, J. | Mortezaee, K.

10

Extracellular vesicle-based checkpoint regulation and immune state in cancer

enthalten in: Medical oncology (Northwood, London, England) | 2022

von Mortezaee, K. | Majidpoor, J.